NASDAQ

Updated Oct 30, 9:27 AM ET

ATEC

Alphatec Holdings, Inc.

−$0.08 (0.70%) Thu · Closed $11.37

−$4.23 (37.20%) ☀ Pre-Market

Oct 30, 9:27 AM ET

About ATEC

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

Mkt Cap
$1.8B
Volume
5.2M
52W High
$23.29
52W Low
$6.82
PE Ratio
—
Avg Vol
2.5M
As of 10/29/26
Div Yield
—
Beta
0.82
As of 10/29/26

Company

Headquarters
Carlsbad, CA
Employees
913 (2026)
Listed
Jun 2, 2006
Exchange
Nasdaq
SEC industry
Surgical & Medical Instruments & Apparatus

Medical Devices

  • Market cap #47 of 163
  • P/B #152 of 152

Ranked highest first among stocks Cylvex covers.

  1. ABTAbbott Laboratories$180.9B+1.88%
  2. ISRGIntuitive Surgical Inc$158.5B+1.03%
  3. MDTMedtronic plc$124.2B+2.46%
  4. SYKStryker Corporation$119.6B+2.55%
  5. BSXBoston Scientific Corp.$61.87B+0.61%
All Medical Devices ›

Financial summary

Related companies

About

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

From company filings and market data · Not investment advice

Price data

Day Low $11.30Day High $12.32
52W Low $6.8252W High $23.29
Open
$11.67
Prev Close
$11.45
Volume
5.2M
Avg Vol (30D)
2.5M

52W range and average volume from daily bars (unadjusted, last 252 sessions).

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.